Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multi-center, Phase I/II Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

NCT05028478 is registered in ClinicalTrials.gov with Curon Biopharmaceutical (Australia) Co Pty Ltd as lead sponsor.

NCT NCT05028478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05028478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multi-center, Phase I/II Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies
Lead sponsor
Curon Biopharmaceutical (Australia) Co Pty Ltd
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 22, 2021
Completion date
October 6, 2023
Enrollment
164 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancies, locally advanced solid tumor, metastatic solid tumor